| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $39,307,746 ) (Continued on the next page) |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35NS105109 | Molecular Mechanisms of Drug Resistance in Primary Brain Tumors | 000 | 8 | NIH | 12/6/2024 | $540,855 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI034206 | Self-Peptides Bound to MHC Class II in T Cell Selection | 001 | 31 | NIH | 12/5/2024 | $0 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI034206 | Self-Peptides Bound to MHC Class II in T Cell Selection | 000 | 31 | NIH | 11/18/2024 | $677,758 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 001 | 4 | NIH | 1/24/2025 | $637,200 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA263299 | A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania | 000 | 4 | NIH | 12/11/2024 | $251,416 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 002 | 6 | NIH | 12/11/2024 | $411,861 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MH135403 | Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | 000 | 2 | NIH | 11/26/2024 | $600,540 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 000 | 8 | NIH | 11/15/2024 | $153,064 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 000 | 10 | NIH | 1/7/2025 | $424,428 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P30CA008748 | Cancer Center Support Grant | 002 | 59 | NIH | 1/27/2025 | $12,112,417 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA297077 | Metabolic control of malignant fates in lung cancer | 000 | 1 | NIH | 11/27/2024 | $730,400 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA295658 | Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | 000 | 1 | NIH | 11/28/2024 | $683,089 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG087529 | Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | 000 | 1 | NIH | 12/17/2024 | $871,093 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA296335 | The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response | 000 | 1 | NIH | 12/12/2024 | $583,973 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01AI187049 | Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE | 000 | 1 | NIH | 12/2/2024 | $597,518 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA296688 | Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization | 000 | 1 | NIH | 12/17/2024 | $263,086 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM156454 | Decoding the Ubiquitin and Autophagy Signaling Networks | 000 | 1 | NIH | 1/30/2025 | $440,000 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21GM152950 | Recombinase polymerase amplification to enable same-cell, DNA/RNA multi-omic single cell sequencing | 000 | 2 | NIH | 12/12/2024 | $199,125 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA286111 | Backup DNA repair in homologous recombination deficient cancers | 000 | 1 | NIH | 11/27/2024 | $487,393 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA270116 | Targeting plasticity in lung cancer | 000 | 3 | NIH | 12/16/2024 | $550,161 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | F99CA294267 | Identifying and Targeting Drivers of Impaired Translation in Tumor-infiltrating CD8+ T-cells. | 000 | 1 | NIH | 1/28/2025 | $3,000 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI100874 | The natural killer cell response against mouse cytomegalovirus infection | 000 | 13 | NIH | 12/4/2024 | $611,381 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA286330 | Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial | 000 | 2 | NIH | 1/23/2025 | $222,156 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA255655 | Genomic biomarkers of splenic lymphoma | 000 | 6 | NIH | 1/9/2025 | $407,568 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA261183 | Immune control and genomic instability at micronuclei | 000 | 4 | NIH | 12/10/2024 | $424,822 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01DK128615 | Genetic susceptibility to Barrett's esophagus: From GWAS to biology | 000 | 4 | NIH | 11/18/2024 | $751,138 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA266478 | Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia | 000 | 4 | NIH | 1/16/2025 | $548,619 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA236579 | Geriatric Oncology: Cognition and Communication | 000 | 6 | NIH | 12/4/2024 | $320,264 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM141553 | Mechanisms of lysosomal ion transport proteins involved in pH homeostasis | 000 | 4 | NIH | 11/21/2024 | $398,250 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI130345 | Development of the resident macrophage lineage in mouse and human | 000 | 8 | NIH | 12/17/2024 | $682,639 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA266185 | Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem Cells | 000 | 4 | NIH | 1/17/2025 | $593,898 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AR068128 | Mechanisms and Function of Myonuclear Positioning | 000 | 10 | NIH | 1/28/2025 | $547,414 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA266068 | Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism | 000 | 3 | NIH | 12/16/2024 | $518,111 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA271186 | Probabilistic Multiscale Modeling of the Tumor Microenvironment | 000 | 3 | NIH | 12/13/2024 | $625,692 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA259161 | Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation | 000 | 4 | NIH | 11/15/2024 | $278,198 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA278599 | Mechanisms of racial disparity in breast cancer-related lymphedema | 000 | 3 | NIH | 12/20/2024 | $661,096 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM088253 | Template-based replication of the centriole organelle | 001 | 15 | NIH | 12/9/2024 | $351,370 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 000 | 3 | NIH | 11/15/2024 | $723,560 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276200 | Defining the function of Complex I truncating mutations in cancer | 000 | 3 | NIH | 12/11/2024 | $571,533 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI182389 | Small-Molecule Penetration and Efflux in Gram-Negative Bacteria | 000 | 2 | NIH | 1/17/2025 | $1,203,141 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01ES036297 | Structural basis of eukaryotic clamp loading | 000 | 2 | NIH | 1/6/2025 | $654,396 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG067598 | Chaperome networks in Alzheimer's disease | 000 | 5 | NIH | 1/23/2025 | $1,033,893 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA255336 | Ceramide-Rich Platforms Functionalize Gemcitabine Uptake | 000 | 5 | NIH | 12/31/2024 | $364,399 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276946 | Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer | 000 | 3 | NIH | 11/15/2024 | $462,767 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA248364 | Leveraging fructose transport to create a privileged substrate to selectively fuel T cells | 000 | 5 | NIH | 11/6/2024 | $627,094 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI155558 | Transcriptional control of NK cell metabolism | 000 | 5 | NIH | 1/23/2025 | $752,874 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA193842 | Characterizing the MSI2 network in leukemia | 000 | 10 | NIH | 11/15/2024 | $371,921 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI072194 | Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation | 000 | 15 | NIH | 12/23/2024 | $515,070 |
| 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM152927 | In vivio single-cell analysis of dynamic cell behaviors | 000 | 2 | NIH | 1/16/2025 | $398,937 |
|